The impact of COVID-19 on the treatment of MDS

What's New in MDS May 19 2021Подробнее

Advice for MDS patients in the COVID-19 eraПодробнее

Hydroxychloroquine and azithromycin for the treatment of COVID-19–Review of study by Didier RaoultПодробнее

MDS & COVID-19 VaccineПодробнее

Coronavirus Pandemic Update 40: Ibuprofen and COVID-19 (are NSAIDs safe?), Trials of HIV medicationsПодробнее

Living with MDS During a PandemicПодробнее

Ask an MS Expert: COVID-19 and MS TreatmentsПодробнее

World's largest study in COVID vaccine side-effects | ABC NewsПодробнее

Predicting outcomes for patients with leukemia and MDS after COVID-19 infectionПодробнее

Impact of COVID-19 on the management of MDSПодробнее

Impact of COVID-19 on AML treatment & managementПодробнее

The impact of COVID-19 on CLL disease managementПодробнее

Evaluating the impact of COVID-19 on patients with movement disordersПодробнее

Coronavirus Pandemic Update 50: Dip in Daily New Deaths; Research on Natural Killer Cells & COVID-19Подробнее

COVID 19 Focus on High Risk MDS and Secondary AML PatientsПодробнее

The Impact of COVID-19 on the Cancer Patient | Dr. Charu AggarwalПодробнее

Coronavirus, Most promising treatment so farПодробнее

The impact of COVID-19 on cancer careПодробнее

Coronavirus Pandemic Update 100: Interferon Beta COVID-19 Treatment, and a RetrospectiveПодробнее

NHS Haematology services during Covid-19 - Update for MDSПодробнее